Elevance Health Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Current	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Jul '26 Jul 28, 2026	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021
Market Cap	83,653	83,859	63,635	77,375	71,744	87,438	98,170	83,917	120,588	125,658	120,584	109,907	102,280	104,791	109,027	122,065	108,563	115,819	118,453	112,075
Market Cap Growth (YoY)	28.50%	-4.09%	-35.18%	-7.80%	-40.51%	-30.42%	-18.59%	-23.65%	17.90%	19.91%	10.60%	-9.96%	-5.79%	-9.52%	-7.96%	8.91%	19.94%	24.36%	34.73%	42.23%
Enterprise Value	104,465	77,528	58,544	73,450	67,759	82,961	94,638	80,579	109,907	117,459	110,870	98,757	88,345	91,738	96,427	111,974	96,486	105,669	107,722	102,146
Last Close Price	385.73	386.73	292.75	350.55	323.12	388.96	434.96	368.90	520.00	541.86	518.54	471.56	435.42	444.29	459.81	512.97	454.24	482.58	491.22	463.54
PE Ratio	17.16	17.19	12.45	13.91	13.21	16.55	16.97	14.37	18.96	19.00	19.60	18.70	17.33	16.89	18.22	21.13	17.95	19.45	19.39	18.58
Forward PE	14.24	14.73	11.28	13.09	10.52	10.99	12.60	11.25	13.12	14.14	13.97	13.17	12.55	13.23	14.02	16.14	14.89	16.28	17.25	16.70
PEG Ratio	3.91	3.83	2.27	14.53	1.33	1.28	1.24	1.25	1.09	1.76	1.17	1.11	1.03	1.20	1.18	1.26	1.24	1.16	1.40	1.17
PS Ratio	0.42	0.42	0.32	0.39	0.37	0.47	0.54	0.48	0.70	0.74	0.71	0.65	0.61	0.64	0.68	0.78	0.71	0.78	0.83	0.82
PB Ratio	1.86	1.87	1.45	1.76	1.63	2.00	2.31	2.03	2.75	2.98	2.97	2.80	2.66	2.74	2.92	3.37	3.02	3.23	3.29	3.11
P/TBV Ratio	15.33	15.15	14.44	17.92	17.31	22.73	46.11	90.31	16.20	21.87	30.74	29.92	38.99	47.42	94.36	80.08	102.44	171.98	105.68	93.51
P/FCF Ratio	13.30	13.33	9.87	24.38	19.05	16.38	26.72	18.44	138.45	153.24	52.52	16.25	12.40	9.91	9.80	16.84	10.44	14.44	16.31	15.40
P/OCF Ratio	11.21	11.24	8.37	18.04	14.61	13.55	20.25	14.45	56.59	60.79	33.78	13.63	10.75	8.86	8.84	14.53	9.37	12.63	14.10	13.40
EV/Sales Ratio	0.52	0.39	0.30	0.37	0.35	0.44	0.52	0.46	0.64	0.69	0.65	0.58	0.53	0.56	0.60	0.72	0.63	0.71	0.75	0.75
EV/EBITDA Ratio	15.79	11.72	8.07	8.83	8.01	9.70	10.72	9.13	11.85	12.20	11.63	10.96	9.45	9.30	10.05	12.18	3.63	4.10	4.30	12.13
EV/EBIT Ratio	21.30	15.81	10.59	11.18	9.79	11.73	12.79	11.07	13.99	14.48	14.00	12.97	11.69	11.41	12.34	14.90	3.86	4.35	4.55	14.35
EV/FCF Ratio	16.61	12.33	9.08	23.14	17.99	15.54	25.76	17.70	126.19	143.24	48.29	14.60	10.71	8.68	8.67	15.45	9.28	13.17	14.83	14.04
Debt / Equity Ratio	0.68	0.68	0.72	0.70	0.71	0.65	0.67	0.71	0.57	0.59	0.58	0.60	0.62	0.66	0.68	0.62	0.60	0.59	0.56	0.59
Debt / EBITDA Ratio	4.69	15.38	13.68	42.73	21.12	11.36	8.86	35.05	16.81	9.42	8.19	16.85	12.61	8.85	8.33	16.24	9.60	9.17	8.76	4.03
Debt / FCF Ratio	4.94	19.09	7.77	-	41.42	16.89	36.54	81.33	11.58	223.27	15.57	-	10.83	15.70	4.13	-	5.15	10.94	10.17	17.29
Net Debt / Equity Ratio	-0.14	-0.14	-0.12	-0.09	-0.09	-0.10	-0.09	-0.08	-0.25	-0.20	-0.24	-0.29	-0.37	-0.34	-0.34	-0.28	-0.34	-0.28	-0.30	-0.28
Net Debt / EBITDA Ratio	-0.98	-3.20	-2.25	-5.42	-2.71	-1.73	-1.08	-3.87	-6.68	-2.83	-3.04	-7.54	-7.13	-4.63	-4.15	-6.85	-4.90	-3.97	-4.06	-1.75
Net Debt / FCF Ratio	-1.03	-3.98	-1.28	19.47	-5.31	-2.58	-4.44	-8.98	-4.60	-66.98	-5.78	3.41	-6.12	-8.22	-2.06	5.61	-2.63	-4.73	-4.72	-7.50
Asset Turnover	0.40	0.40	0.40	0.41	0.42	0.42	0.42	0.40	0.39	0.39	0.38	0.40	0.40	0.41	0.40	0.40	0.39	0.39	0.39	0.39
Quick Ratio	1.38	1.38	1.32	1.41	1.43	1.32	1.31	1.32	1.34	1.32	1.23	1.30	1.29	1.32	1.31	1.27	1.21	1.22	1.23	1.33
Current Ratio	1.52	1.52	1.48	1.54	1.56	1.44	1.43	1.45	1.50	1.49	1.37	1.44	1.41	1.44	1.43	1.40	1.35	1.36	1.36	1.47
Return on Equity (ROE)	3.27%	3.27%	4.06%	1.28%	2.70%	4.05%	5.24%	1.02%	2.45%	5.71%	5.75%	2.19%	3.49%	5.00%	5.45%	2.42%	4.45%	4.61%	5.09%	3.40%
Return on Assets (ROA)	1.00%	1.00%	1.23%	0.31%	0.80%	1.48%	2.03%	0.30%	0.83%	1.81%	2.01%	0.84%	1.14%	1.74%	1.90%	0.85%	1.51%	1.70%	1.81%	4.66%
Return on Invested Capital (ROIC)	3.21%	3.21%	3.83%	0.92%	2.42%	4.43%	6.12%	0.95%	2.81%	6.18%	7.52%	3.36%	4.89%	7.33%	7.80%	3.39%	6.14%	6.59%	6.90%	16.90%
Return on Capital Employed (ROCE)	2.06%	2.06%	2.51%	0.18%	1.45%	3.05%	4.17%	0.69%	1.82%	3.75%	4.31%	1.64%	2.40%	3.73%	4.06%	1.61%	3.25%	3.52%	3.78%	8.93%
Earnings Yield	5.93%	5.82%	8.03%	7.19%	7.57%	6.04%	5.89%	6.96%	5.27%	5.26%	5.10%	5.35%	5.77%	5.92%	5.49%	4.73%	5.57%	5.14%	5.16%	5.38%
FCF Yield	7.52%	7.50%	10.14%	4.10%	5.25%	6.10%	3.74%	5.42%	0.72%	0.65%	1.90%	6.16%	8.06%	10.09%	10.21%	5.94%	9.58%	6.93%	6.13%	6.49%
Dividend Yield	1.78%	0.44%	0.58%	0.48%	0.53%	0.44%	0.39%	0.44%	0.31%	0.30%	0.31%	0.31%	0.34%	0.33%	0.32%	0.25%	0.28%	0.27%	0.26%	0.24%
Payout Ratio	30.57%	25.50%	21.32%	68.92%	32.04%	22.09%	17.68%	89.23%	37.20%	16.43%	16.87%	40.42%	27.00%	18.89%	17.65%	35.26%	19.09%	18.88%	17.27%	22.92%
Buyback Yield / Dilution	3.64%	3.50%	2.99%	4.02%	4.03%	3.26%	2.99%	1.99%	1.44%	1.85%	2.29%	2.24%	2.35%	2.30%	1.92%	1.75%	1.54%	1.62%	1.53%	2.23%
Total Shareholder Return	5.43%	3.94%	3.58%	4.51%	4.56%	3.70%	3.38%	2.43%	1.75%	2.15%	2.61%	2.55%	2.69%	2.63%	2.24%	2.00%	1.83%	1.88%	1.79%	2.47%

SEC Filings: 10-K · 10-Q